Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

GlaxoSmithKline Will Split Into 2

Video Credit: Wochit - Duration: 00:46s - Published < > Embed
GlaxoSmithKline Will Split Into 2

GlaxoSmithKline Will Split Into 2

LONDON (Reuters) - GlaxoSmithKline plans to split into two businesses — one for prescription drugs and vaccines, the other for over-the-counter products — after forming a new joint venture with Pfizer’s consumer health division.

The logo of U.S. pharmaceutical corporation Pfizer Inc.

Is seen at a branch in Zurich, Switzerland October 2, 2018.

REUTERS/Arnd Wiegmann The revamp is the boldest move yet by GSK Chief Executive Emma Walmsley, who took over last year.

0
shares
ShareTweetSavePostSend
 

Recent related news from verified sources

Mylan launches Advair generic at one-third price

Mylan NV on Tuesday priced its generic version of GlaxoSmithKline's blockbuster asthma treatment...
Reuters - Published

GSK Consumer Healthcare's Q3 net profit up 35%

GlaxoSmithKline (GSK) Consumer Healthcare on Thursday reported a 35.07 per cent rise in net profit...
Sify - Published

Bharat Biotech to acquire rabies vaccine maker Chiron Behring

Bharat Biotech on Friday announced that it has signed an agreement with GlaxoSmithKline Asia to...
Sify - Published


You Might Like


Recent related videos from verified sources

GSK looks to new chapter [Video]GSK looks to new chapter

► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs FT pharmaceuticals correspondent Andrew Ward and Lex editor Robert Armstrong discuss whether GlaxoSmithKline can ease..

Credit: Financial Times     Duration: 03:40Published

Novartis/GSK -- expensive restructuring? [Video]Novartis/GSK -- expensive restructuring?

GlaxoSmithKline has struck a three-way agreement worth $16bn with Novartis to reorganise their businesses. Lex's Joseph Cotterill and Robert Armstrong discuss whether the reorganisation aids a prime..

Credit: Financial Times     Duration: 02:52Published

GSK in China - where now? [Video]GSK in China - where now?

► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs GlaxoSmithKline must pay the largest corporate fine ever levied in China after its subsidiary there was found guilty of..

Credit: Financial Times     Duration: 03:25Published

GSK's challenging year | FT Business [Video]GSK's challenging year | FT Business

► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs Sir Andrew Witty, chief executive of GlaxoSmithKline, talks to the FT's pharmaceuticals correspondent Andrew Ward about a..

Credit: Financial Times     Duration: 04:35Published

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest